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ABSTRACT
Background Evidence on the effect of pay- for- 
performance (P4P) schemes on provider performance 
is mixed in low- income and middle- income countries. 
Brazil introduced its first national- level P4P scheme in 
2011 (PMAQ- Brazilian National Programme for Improving 
Primary Care Access and Quality). PMAQ is likely one 
of the largest P4P schemes in the world. We estimate 
the association between PMAQ and hospitalisations for 
ambulatory care sensitive conditions (ACSCs) based on a 
panel of 5564 municipalities.
Methods We conducted a fixed effect panel data analysis 
over the period of 2009–2018, controlling for coverage of 
primary healthcare, hospital beds per 10 000 population, 
education, real gross domestic product per capita and 
population density. The outcome is the hospitalisation rate 
for ACSCs among people aged 64 years and under per 10 
000 population. Our exposure variable is defined as the 
percentage of family health teams participating in PMAQ, 
which captures the roll- out of PMAQ over time. We also 
provided several sensitivity analyses, by using alternative 
measures of the exposure and outcome variables, and 
a placebo test using transport accident hospitalisations 
instead of ACSCs.
Results The results show a negative and statistically 
significant association between the rollout of PMAQ and 
ACSC rates for all age groups. An increase in PMAQ 
participating of one percentage point decreased the 
hospitalisation rate for ACSC by 0.0356 (SE 0.0123, 
p=0.004) per 10 000 population (aged 0–64 years). 
This corresponds to a reduction of approximately 60 
829 hospitalisations in 2018. The impact is stronger for 
children under 5 years (−0.0940, SE 0.0375, p=0.012), 
representing a reduction of around 11 936 hospitalisations. 
Our placebo test shows that the association of PMAQ 
on the hospitalisation rate for transport accidents is not 
statistically significant, as expected.
Conclusion We find that PMAQ was associated with a 
modest reduction in hospitalisation for ACSCs.
INTRODUCTION
Recent reviews have challenged low- income 
and middle- income countries (LMICs) that 
have adopted pay- for- performance (P4P) 
schemes in primary healthcare (PHC), by 
showing very low- certainty and evidence about 
the effect of P4P on provider performance, 
Key questions
What is already known?
 ► Despite the rapid expansion over the last decade, it 
is unclear the contribution of pay- for- performance 
(P4P) schemes in low- income and middle- income 
countries, particularly when related to health 
outcomes.
 ► Brazilian National Programme for Improving Primary 
Care Access and Quality (PMAQ) is likely one of the 
largest P4P schemes in the world, reaching around 
39 000 Family Health Teams.
What are the new findings?
 ► We show that expansion of the PMAQ was associ-
ated with a modest reduction in avoidable hospital-
isations for all age groups, with stronger impact for 
children under 5 years.
 ► When stratifying by age group and diseases that 
accounted for a high proportion of ambulatory care 
sensitive conditions, we found that PMAQ expansion 
was associated with a reduction in hospitalisations 
for gastroenteritis for 0–4 years, asthma for 5–19 
years and renal disease for 20–64 years.
What do the new findings imply?
 ► The findings provide evidence that P4P can con-
tribute to improve quality of care at primary health-
care setting, particularly by reducing avoidable 
hospitalisations.
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utilisation of services, patient outcomes and resource 
use.1–3 Moreover, evidence from LMICs is skewed towards 
donor- oriented approaches, since most P4P schemes 
have been driven and funded by international organi-
sations,4 often implemented disassociated from existing 
health system institutions.5 6 Additionally, the effects of 
P4P schemes have typically been assessed at only one 
point in time.4
After nearly two decades of continuing reforms 
and strengthening of PHC,7 Brazil introduced its first 
national- level P4P scheme, called the Brazilian National 
Programme for Improving Primary Care Access and 
Quality (PMAQ, acronym in Portuguese) in 2011. PMAQ 
was rolled out over three rounds of implementation: 
round 1 (November 2011–Mar 2013), round 2 (April 
2013–September 2015) and round 3 (October 2015–
December 2019). During three rounds, the Brazilian 
Ministry of Health provided financial incentives for a wide 
variety of structure, process and outcome indicators,8 
aiming to improve access and quality of PHC. To achieve 
these goals, some challenges should be overcome, such 
as poor health facility infrastructure, inadequate working 
conditions, high turnover of health professionals, low 
integration of PHC facilities with healthcare networks 
(secondary and tertiary levels), rare evaluative culture at 
facility level, and underinvestment in information tech-
nologies to support decision- making process.9
Participation in PMAQ has increased rapidly over the 
three rounds of implementation, reaching 38 864 family 
health teams (FHTs) in the third round, representing 
89.5% of the total number of teams across the country 
in 2018. PMAQ has received RS 13.5 billion (US$ 2.7 
billion) from 2011 to 2019. Despite 9 years of imple-
mentation, PMAQ is still underevaluated in terms of its 
effects on endpoint outcomes. Studies relied mainly on 
descriptive analyses,10 based on a subset of data on struc-
ture, access, service organisation and management indi-
cators, generally for a specific health condition such as 
diabetes,11 antenatal care,12 cervical cancer screening,13 
user’s satisfaction14 and work processes.15
Hospitalisation rate for ambulatory care sensitive 
conditions (ACSCs) have been used as an indirect indi-
cator of the effectiveness and quality of PHC.16 ACSCs 
are a set of diseases and health problems for which timely 
and high- quality PHC reduces the risk of inpatient admis-
sion. Previous studies have investigated the relationship 
between P4P scheme and ACSCs showing mixed results. 
The Portuguese experience showed no significant impact 
of the P4P scheme on the hospitalisation rate for ACSCs17 
; while the English experience found a reduction on 
the ACSCs incentivised by the Quality Outcome Frame-
work (QOF).18 19 In the USA, two out of three states 
that implemented P4P schemes presented reduction in 
ACSC hospitalisations.20 In Brazil, we identified a study 
that found a decline in hospitalisation for ACSCs due to 
PMAQ in the first 4 years of PMAQ implementation.21 
However, the latter study covered the first two rounds of 
PMAQ (2010–2014) and used a dichotomous measure 
of exposure (=1 if municipality participated in PMAQ), 
which may not reflect the implementation intensity of 
PMAQ over time.
By improving access and quality of primary care, it is 
expected that PMAQ would deliver more prevention 
and better treatment at PHC level, which would result 
in fewer hospitalisations for ACSCs. Based on that, the 
objective of our study is to estimate the association of 
PMAQ on hospitalisations for ACSCs, using a fixed effect 
(FE) panel data approach of 5564 municipalities from 
2009 to 2018, controlling for observed demographic, 
socioeconomic and health supply- side covariates.
METHODS
Study setting
Brazil created the Unified Health System (Sistema Único 
de Saúde - SUS, in Portuguese) in 1990, financed by 
general taxation and since then it has made consistent 
progress towards achieving universal health coverage by 
providing formally under the law, universal, equitable 
and comprehensive healthcare free of charge at the point 
of service.22 Around 75% of the Brazilian population 
receives healthcare only through the SUS, while 25% have 
private insurance coverage.23 PHC was nationally imple-
mented in 1994, focusing on families and communities 
and integrating medical care with health promotion and 
public health actions, including epidemiological surveil-
lance.24 PHC is provided mainly through three channels: 
(1) the FHT, composed of at least one physician, a nurse, 
a nurse assistant and a community health agent; (2) the 
oral health team (OHT), composed of at least one dentist 
and a dentist assistant and (3) the Family Health Support 
Unit (NASF), composed of mental health, rehabilitation, 
nutrition, maternal and childcare staff, pharmacy and 
social assistance workers.
PMAQ was one of the strategies aimed at improving 
PHC that occurred simultaneously and as part of a 
broader set of changes introduced at the federal level. 
In 2011, when PMAQ was implemented, the National 
Primary Healthcare Policy was revised,25 resulting in26–30: 
(1) increasing of financial transfers from the Ministry 
of Health to PHC and adoption of equity criteria in 
health resource allocation; (2) expansion of the Family 
Health Strategy (FHS) modalities that could receive 
federal funding, including fluvial health facilities that 
delivery care to populations living in deprived riverside 
communities; (3) implementation of Requalifica UBS, a 
programme that provided financial resources to improve 
the structure of PHC facilities, such as construction and 
refurbishments; (4) investments in information systems, 
aiming at implementing a new PHC information system 
(e- SUS) and telehealth (Telessaúde Brasil Rede); (5) 
expansion of NASF, including other healthcare workers; 
(6) expansion of the programmes for health promotion 
and prevention in schools (Programa Saúde na Escola) 
and homecare delivery (Programa Melhor em Casa); 
(7) implementation of the Programme to Value Primary 
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Healthcare Professionals (PROVAB), which offered 
training and scholarships for doctors who work in highly 
vulnerable and deprived areas; and (8) implementation 
of More Doctor Programme (Programa Mais Médicos) in 
2013, involving an emergency expansion of PHC doctors 
(allowing the hiring of foreign doctors), an increasing 
number of PHC residency positions, and increasing 
investments in the infrastructure of PHC facilities.
The PMAQ scheme
The PMAQ scheme was intended to strengthen primary 
care by increasing resources allocated from the Ministry 
of Health to municipalities, with the level of resources 
determined by the performance of primary care teams 
within the municipality. Municipalities decide whether 
to disburse financial incentives directly to healthcare 
providers or teams or to use the financial resources 
for other purposes related to PHC.8 Participation in 
PMAQ is voluntary, and municipalities have autonomy 
to indicate which of their teams would be engaged 
in the programme. Only the FHT and the OHT were 
eligible to participate in the first round of the PMAQ 
(November 2011–March 2013). NASF was included in 
the second (April 2013–September 2015) and third 
rounds (October 2015–December 2019). Only 50% of 
FHTs within a municipality could participate in the first 
round of PMAQ. In the following rounds, this restriction 
did not apply.
Teams are evaluated through self- assessment, routine 
monitoring and external evaluation, resulting in 
hundreds of structure, process and outcome indicators 
in each round (598 in round 1; 914 in round 2; and 660 
in round 3).31 Structural indicators include availability of 
drugs and equipment, patient’s privacy during consul-
tations and procedures, and users’ accessibility. Process 
indicators include content of antenatal care, treatment 
completion rates, consultation for routine monitoring 
(ie, diabetes, hypertension, asthma), number of consul-
tations for selected diseases, and proportion of appoint-
ments that are scheduled. Outcome indicators include 
patients’ satisfaction, birth weight of children and preva-
lence of chronic disease.
Study design
We conducted a FE panel data analysis to measure the 
association of PMAQ on the hospitalisation rate for 
ACSCs over the period 2009–2018. FE models provide 
a method for assessing exposure/outcome associa-
tions (PMAQ/hospitalisation for ACSCs, in our study) 
adjusting for time- invariant confounders (municipal 
characteristics) and measuring time- varying confounders 
(socioeconomic, demographic, and supply- side varia-
bles).32 The unit of analysis is the municipality because 
the final decision about the PMAQ engagement is taken 
at this administrative level. We introduced novel aspect 
to the model by considering a measure of PMAQ imple-
mentation intensity. Instead of having a dichotomous 
measure of exposure (yes/no), we used the percentage of 
PMAQ participating teams related to the total number of 
FHTs for each municipality, which may better reflect the 
expansion of PMAQ over time (three rounds of PMAQ).
Variables and sources
The primary outcome is the age- adjusted hospitalisation 
rate for ACSCs, defined as the number of hospitalisations 
for ACSCs among people under 64 years of age per 10 
000 population. Hospital admissions were available at 
municipal level. We excluded patients aged over 65 years 
because such individuals are likely to have a high preva-
lence of other diseases than those related to ACSCs, which 
may not be affected by timely and high- quality PHC. We 
used the Brazilian list for ACSCs, which was developed by 
the Ministry of Health based on the International Classi-
fication of Diseases (ICD-10).33 A complete description 
of the diseases and health conditions included in the 
Brazilian list of ACSCs can be found in online supple-
mental table S1. The list included 19 diseases or health 
conditions and all of them were incentivised by PMAQ. 
Additionally, we also included alternative outcomes, 
such as hospitalisation rate for ACSCs stratified by age 
group (0–4 years, 5–19 years and 20–64 years) and the 
most frequent causes of ACSCs (causes that account for 
more than 10% of hospitalisations for ACSCs). We used 
age- adjusted hospitalisation rates for adults (aged 20–64 
years) and the overall population (aged 0–64 years). Age- 
adjusted rates were calculated using the direct method of 
standardisation.34 Data were extracted from the Hospital 
Information System (SIH/DATASUS).35
Our exposure variable is defined as the percentage of 
the PMAQ teams in terms of total number of FHT. FHTs 
include teams of the FHS and primary health teams. The 
PMAQ participating teams that were assigned as ‘unsat-
isfactory’ or ‘declassified’ by the Ministry of Health were 
excluded from the database, since these teams have not 
been exposed to PMAQ scheme during the whole round. 
This assumption was relaxed in the sensitivity analysis. 
‘Unsatisfactory’ means that teams have not complied 
with the rules of PMAQ and ‘declassified’ encompasses 
three situations: (1) teams have asked to be formally 
removed from the PMAQ; or (2) teams have refused to 
be evaluated by the external evaluation; or (3) teams did 
not have a dental chair. Data were obtained from the 
Primary Healthcare System (SAPS/Ministry of Health).36 
Although PMAQ started in November 2011, municipali-
ties and FHT had been aware of its existence since very 
early 2011. On this basis, we considered 2011 as initial 
year of PMAQ programme.
We included a set of covariates usually associated with 
hospitalisation rate for ACSCs that could be regarded 
as confounding variables such as: coverage of PHC, 
hospital beds per 10 000 population, education index, 
gross domestic product (GDP) per capita (adjusted by 
General Price Index) and population density. For educa-
tion index, we used the FIRJAN Index of Municipal 
Development for education (IFDM), which includes six 
indicators: (1) enrolment in early childhood education, 
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primary school leaver, age- grade distortion in primary 
school, percentage of teachers with a degree qualifi-
cation in primary school, average daily lesson hours in 
primary school and Basic Education Development Index 
result in primary school.37 The education index ranges 
from 0 to 1, where higher values indicate greater devel-
opment of the municipal units. For the education index 
and GDP per capita, data were not available for 2018 
and 2017–2018, respectively, in which case we estimated 
annual values by linear extrapolation. PHC coverage was 
obtained from the Primary Healthcare System (SAPS/
Ministry of Health),36 hospital beds from the National 
Registry of Health Facilities (CNES/DATASUS),38 educa-
tion index from the Federation of Industries of the State 
of Rio de Janeiro (FIRJAN),37 and GDP per capita and 
population were from the Brazilian Institute of Geog-
raphy and Statistics (IBGE).39 All covariates were avail-
able at municipal level.
Statistical analyses
Descriptive analyses were undertaken, including national 
trends of overall and most frequent ACSC hospitalisation 
rates stratified by age group. FE panel data regressions 
were used to assess the association between municipal- 
level hospitalisation rates for ACSCs and the percentage 
of FTHs that participated in PMAQ.
The equation for the FE model can be written as:
 ACSCit = α+ γPMAQit + βXit + δi + θt + εit (1)
where  ACSCit  is the hospitalisation rate for ACSCs in the 
municipality i at year t.  PMAQit  is the percentage of FHTs 
participating in PMAQ.  Xit  is a vector of covariates that 
capture time- varying characteristics of municipality i at 
year t.  δi  is the municipality FE, which account for time- 
invariant characteristics that could affect the hospitalisa-
tion rates.  θt  is the year FE and captures any time- specific 
shock.  εit  is the error term. Standard errors were clustered 
at the level of municipality.
FE estimates account for time invariant unobserved 
heterogeneity and omitted variable bias, and hence 
are more appropriate for programme evaluation than 
random effects (RE) estimates.40 Hausman specification 
test41 was also performed to test whether there is a system-
atic difference between FE and RE estimates. The null 
hypothesis was rejected, indicating that FE is preferable 
to RE.
Sensitivity analyses
We performed several sensitivity analyses. First, we esti-
mated equation (1) by age group and most frequent 
causes of ACSCs. Second, we also included ‘unsatis-
factory’ or ‘declassified’ teams in PMAQ participating 
teams, that is, the numerator of exposure variable 
(PMAQ) increased. Although these teams were not fully 
exposed to the incentive scheme, they adhered at the 
beginning of the PMAQ round. Third, we used a dummy 
to define PMAQ exposure (=1 if at least one team have 
participated in PMAQ). Fourth, we used the crude hospi-
talisation rate for ACSCs instead of the adjusted rate, 
conducting the same analysis for overall and adult hospi-
talisations. Fifth, we estimated our main model, equation 
(1), using the negative binomial distribution. Finally, we 
performed a placebo test to support the validity of our 
empirical strategy. Placebo test was conducted using the 
hospitalisation rate for transport accident (ICD-10 codes: 
V01–V99).
Patient and public involvement statement
Patients and public were not directly involved in this 
research. We used publicly available data.
RESULTS
Since its implementation, PMAQ expanded rapidly, 
reaching on average 50.1% of the FHTs in the first round 
(2011–2012), 75.7% in the second round (2013–2015) 
and 86.9% in the third round (2016–2018), not consid-
ering teams classified as unsatisfactory or declassified. In 
2018, 95.6% of the Brazilian municipalities had at least 
one FHT enrolled in PMAQ (table 1).
The average adjusted hospitalisation rate for ACSCs 
for population 0–64 years old decreased by 26.8% (from 
127.9 per 10 000 population in 2009 to 93.6 per 10 000 in 
2018). Considering the most frequent causes of hospital-
isations for ACSCs, there was a large reduction in hospi-
talisation rates due to gastroenteritis for all age groups 
(ranging from 44.3% to 52.9%). Hospitalisation rates 
for asthma also showed a large decline over the period 
(around 54% for both younger groups of age) (figure 1).
Regarding the covariates used in the FE model, only 
hospital beds has decreased over the period under 
investigation, a reduction of 14.6% from 2009 to 2018. 
Although there is some oscillation within the period, the 
other covariates increased from the base line to 2018 
(table 2).
Table 3 presents the association between the percentage 
of teams enrolled in PMAQ and ACSC rates. All estimates 
included year dummies and used robust standard errors 
clustered by municipality. An increase of PMAQ of one 
percentage point decreased the hospitalisation rate for 
ACSC by 0.0356 per 10 000 population (aged 0–64 years). 
Taking the participation in PMAQ of 89.5% of the total 
teams, this corresponds to a reduction of 3% of the mean 
hospitalisation rate for ACSC, or approximately 60 829 
(95%CI 19 705 to 1 01 879) hospitalisations in 2018. The 
impact is stronger for children under five (−0.0940 per 
10 000 children under 5 years old), representing a reduc-
tion of around 11 936 hospitalisations in this age group 
in 2018.
The estimated coefficients of PMAQ for the most 
frequent causes of hospitalisations for ACSCs by age 
group are presented in figure 2. Higher levels of team 
enrolment in PMAQ decreased the hospitalisation rate 
for gastroenteritis only for 0–4 years. Higher levels of 
team enrolment in PMAQ was also associated with fewer 
hospitalisation rate for asthma (0–4 years and 5–19 years) 
and renal disease (20–64 years). For other diseases, 
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PMAQ coefficient was not statistically significant (online 
supplemental appendix 1).
Our sensitivity analyses included a placebo test to 
support the validity of our empirical strategy. As a placebo 
variable, we use hospitalisation rates for transport acci-
dents (0–64 years), which is not expected to be related 
to access and quality of primary care, and therefore with 
exposure to PMAQ. As expected, the association between 
PMAQ and the hospitalisation rate for transport acci-
dents is not statistically significant (online supplemental 
appendix 2).
Additionally, equation (1) was estimated using an 
alternative definition of PMAQ. First, we included teams 
that were assigned as ‘unsatisfactory’ or ‘declassified’ by 
the Ministry of Health (column 2, online supplemental 
appendix 3), showing similar results as shown in table 2. 




No of municipalities 
enrolled in PMAQ*
No of PMAQ 
teams
No of PMAQ teams classified as 
unsatisfactory or declassified
No of family 
health teams†
2009 5569 0 0 0 30 897
2010 5569 0 0 0 32 242
2011 5569 3965 17 482 644 33 213
2012 5569 3965 17 482 644 33 979
2013 5569 5071 30 522 1008 35 850
2014 5569 5071 30 522 1008 39 753
2015 5569 5071 30 522 1008 41 302
2016 5569 5323 38 864 1820 41 483
2017 5569 5323 38 864 1820 42 896
2018 5569 5323 38 864 1820 43 408
*Municipality has at least one PMAQ team. ‘Unsatisfactory’ means that teams have not complied with the rules of PMAQ. ‘Declassified’ 
complies three situations: (1) teams have asked to be formally removed from the PMAQ or (2) teams have refused to be evaluated by the 
external evaluation or (3) teams that did not have a dental chair.
†Number of family health teams in December of each year.
FHTs, family health teams; PMAQ, Programme for Improving Primary Care Access and Quality.
Figure 1 Trends in hospitalisation rates for ACSCs by age group (A) and most frequent causes of ACSCs by specific age 
group (B–D), 2009–2018, Brazil. ACSCs, ambulatory care sensitive conditions.
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The PMAQ coefficient was −0.0379 (p<0.001) for those 
aged 0–64 years. Second, we used a dummy to define 
PMAQ exposure (=1 if at least one team have partici-
pated in PMAQ), which showed no statistical significance 
(column 3, online supplemental appendix 3). Third, we 
used the crude hospitalisation rate for ACSCs instead 
of the adjusted rate (column 4, online supplemental 
appendix 3). PMAQ was associated with a reduction on 
ACSCs, with a coefficient of −0.0369 (p<0.001) for those 
aged 0–64 years. Fourth, we estimated equation (1) using 
the negative binomial distribution (column 4, online 
supplemental appendix 3). The effect of the variables 
is expressed as incidence rate ratio (IRR). We found 
that one unit increase in PMAQ leads to a reduction in 
the rate of 0.04%. Taking the participation in PMAQ of 
89.5% of the total teams in 2018, it represents a reduc-
tion of 3.58% in the mean hospitalisation rate for ACSCs. 
This shows a modest reduction in the hospitalisation rate, 
as found in our main analyses (table 3).
DISCUSSION
This study found the roll out of PMAQ across municipal-
ities was associated with a modest but significant reduc-
tion in avoidable hospitalisations (all ACSCs) for popu-
lations aged 0–64 years during the three rounds of the 
programme (2011–2018). PMAQ was associated with a 
reduction of around 60 829 (95% CI 19 705 to 101 879) 
ACSCs for populations aged 0–64 years in 2018. When 
stratifying by age group and diseases that accounted for 
a high proportion of ACSCs, PMAQ expansion was asso-
ciated with a reduction in hospitalisations for gastroen-
teritis for 0–4 years (−0.048; 95% CI −0.088 to –0.007), 
asthma for 5–19 years (−0.007; 95% CI −0.013 to –0.002) 
and renal disease for 20–64 years (−0.010; 95% CI −0.016 
to –0.003). Our results are in line with other study carried 
out in Brazil, which found that PMAQ was associated 
with a 9% reduction in hospitalisations for ACSCs.21 We 
found that an increase of 89.5% of PMAQ participating 
reduce by 3% of the mean hospitalisation rate for ACSCs. 
However, our approach differs from their study in some 
important ways. We use a longer time period, consider the 
implementation intensity of PMAQ (instead of a dichot-
omous variable) and control for year dummies. In our 
sensitivity analyses, the dichotomous measure of expo-
sure became non- statistically significant after including 
year dummies.
Qualitative studies provide some insights into the 
potential mechanisms underpinning the effect of PMAQ 
on avoidable hospitalisations. Previous studies have 
reported improvements in work processes and planning 
at the team level. These managerial tools are important to 
achieve improvements in access and quality of care. For 
example, home visits, support from other professionals 
and referral to specialised care when needed have been 
associated with lower rates of avoidable hospitalisations.42 
In the state of Paraná, workers engaged in PMAQ have 
reported improvements in health information registries 
(allowing better monitoring of target populations) and 
the indicators from the external evaluation provided a 
good overview of what should be improved at team level.43 
On the other hand, qualitative studies conducted in state 
of Goiás and São Paulo showed a low perception of the 
PMAQ impact on clinical practices and work process,15 44 
mainly due to a top- down approach adopted during the 
implementation of PMAQ, lack of knowledge about 
the programme and absence of feedback regarding the 
results of external evaluation. These problems tend to 
demotivate health worker and consequently jeopardise 
the access and quality delivered though PMAQ teams.
Other studies have investigated the effect of P4P 
schemes on ACSCs worldwide. In England, hospitalisa-
tion for ACSCs incentivised by QOF reached a reduction 
of 2.7% (95% CI 1.6% to 3.8%) and 8.0% (95% CI 6.9% 
to 9.1%) in the first and the seventh year after QOF was 
introduced, respectively, compared with ACSCs that were 
not incentivised by the programme.18 A more recent study 
conducted in England suggested that QOF was associated 
with a smaller reduction in incentivised ACSC hospital-
isations (IRR 0.993; 95% CI 0.990 to 0.995), where a 1% 
increase in quality of care corresponds to a decrease of 
187 hospitalisations for all incentivised conditions in the 
period of 2015–2016 at national level.19
In Portugal, a difference- in- difference study indicated 
that municipalities that implemented P4P scheme at 
FHTs had no statistically significant impact on hospital-
isations for ACSCs compared with municipalities that 
did not implement the scheme.17 It is worth noting that 
our study included 19 diseases- related ACSCs, while the 
English and Portuguese studies included only 8 and 4 
diseases- related ACSCs incentivised by its P4P scheme, 
respectively, and this might have led to a difference in 
interpretation, as the current study shows a much broader 
Table 2 Descriptive statistics for Brazilian municipalities, 2009–2018
Covariates 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Primary care (%) 86.87 87.60 88.19 88.54 89.97 92.04 92.54 92.22 92.94 92.76
Education (IFDM) 0.66 0.68 0.71 0.72 0.74 0.75 0.76 0.77 0.77 0.78
GDP pc 18 901 19 430 21 392 21 643 22 616 23 463 21 974 22 296 23 328 23 167
Hospital beds 18.30 18.16 17.77 17.41 16.61 16.53 16.17 15.98 15.74 15.62
Population density 109.45 108.19 109.11 109.99 113.99 114.97 115.92 116.87 117.78 118.57
GDP, gross domestic product; IFDM, FIRJAN Index of Municipal Development.
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description of impact of P4P scheme. In the USA, using a 
propensity score matching of physicians exposed to P4P 
versus non- exposed to P4P and a difference- in- difference 
approach at patient level, a study found that two out of 
three states that implemented P4P schemes had a reduc-
tion on ASCS hospital admissions.20 These results are 
robust to several regression specifications and matching 
methods.
Strengths and weaknesses of this study
Although we have not claimed that our results reflect 
the impact of PMAQ on avoidable hospitalisations, we 
provided robust estimates of its association on ACSCs. We 
controlled for confounders at municipality level and we 
performed several sensitivity analyses. Moreover, we used 
a rich panel dataset covering all Brazilian municipali-
ties over a 10- year period. Regardless, some limitations 
Table 3 Estimation results for hospitalisation rates for ACSC using fixed effects by age group, 2009–2018, Brazil
0–64 years 0–4 years 5–19 years 20–64 years
PMAQ −0.036*** −0.094** −0.022** −0.035***
(−0.060 to −0.012) (−0.168 to −0.020) (−0.041 to −0.002) (−0.061 to −0.010)
Primary care coverage −0.099*** −0.310*** −0.060** −0.094***
(−0.168 to −0.030) (−0.513 to −0.107) (−0.115 to −0.005) (−0.164 to −0.025)
Education index −15.416 −3.852 −6.222 −14.211
(−35.762 to 4.930) (−83.940 to 76.236) (−22.918 to 10.475) (−34.893 to 6.470)
GDP pc −0.000** −0.000 −0.000*** −0.000**
(−0.000 to −0.000) (−0.000 to 0.000) (−0.000 to −0.000) (−0.000 to −0.000)
Hospital beds 0.868*** 1.233*** 0.598*** 0.944***
(0.648 to 1.088) (0.726 to 1.741) (0.422 to 0.775) (0.716 to 1.171)
Population density 0.050*** 0.116*** 0.027*** 0.051***
(0.033 to 0.068) (0.070 to 0.162) (0.019 to 0.036) (0.027 to 0.076)
d2010 2.125*** 21.326*** 1.364** 0.813
(0.820 to 3.430) (16.516 to 26.135) (0.121 to 2.608) (−0.552 to 2.177)
d2011 −8.639*** −33.807*** −3.593*** −6.076***
(−10.797 to −6.481) (−40.981 to −26.633) (−5.472 to −1.715) (−8.321 to −3.831)
d2012 −14.275*** −33.829*** −6.628*** −13.532***
(−16.697 to −11.854) (−41.749 to −25.910) (−8.687 to −4.569) (−16.030 to −11.034)
d2013 −14.203*** −40.734*** −4.231*** −14.385***
(−17.377 to −11.028) (−51.166 to −30.301) (−6.887 to −1.576) (−17.712 to −11.057)
d2014 −16.127*** −31.071*** −4.868*** −17.266***
(−19.382 to −12.872) (−41.703 to −20.439) (−7.565 to −2.171) (−20.660 to −13.873)
d2015 −22.738*** −51.696*** −10.956*** −21.952***
(−26.266 to −19.209) (−63.146 to −40.245) (−13.844 to −8.068) (−25.611 to −18.292)
d2016 −25.988*** −49.553*** −13.376*** −26.576***
(−29.765 to −22.210) (−61.821 to −37.286) (−16.463 to −10.289) (−30.505 to −22.646)
d2017 −26.025*** −55.007*** −13.628*** −26.021***
(−29.926 to −22.124) (−67.108 to −42.905) (−16.863 to −10.393) (−30.096 to −21.946)
d2018 −26.903*** −52.453*** −17.569*** −25.826***
(−30.923 to −22.884) (−64.799 to −40.107) (−20.797 to −14.340) (−30.041 to −21.611)
Constant 126.447*** 299.922*** 70.074*** 123.592***
(110.679 to 142.215) (242.878 to 356.967) (57.171 to 82.977) (107.660 to 139.524)
Observations 55 640 55 640 55 640 55 640
R- squared 0.076 0.032 0.037 0.073
No of id 5564 5564 5564 5564
95% CIs in brackets.
*P<0.1,**P<0.05,***P<0.01.
ACSCs, ambulatory care sensitive conditions; GDP, gross domestic product; PMAQ, Programme for Improving Primary Care Access and 
Quality.
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have remained. First, we have treated our exposure as a 
homogenous variable, but in fact PMAQ can be imple-
mented in different ways at the municipal level. Munici-
palities decide whether to distribute the PMAQ rewards 
in kind (training activities, additional drugs and supplies, 
equipment) or in cash to teams. Second, we used the 
official Brazilian Ministry of Health list of ACSCs as 
outcome, which comprised 19 diseases or health condi-
tions. However, not all of them were explicitly incentiv-
ised by PMAQ scheme. As a result, our estimates are likely 
to be conservative. Third, other programmes were imple-
mented in the PHC in the period investigated in this 
study, such as the More Doctors Programme (Programa 
Mais Médicos (PMM)). PMM was designed to overcome 
the insufficiency and turnover of physicians across the 
country, especially in remote and deprived areas. Studies 
have shown that PMM was associated with a modest but 
significant reduction on ACSC hospitalisations45 and 
amenable mortality.46 We have not controlled for PMM 
because data were not publicly available for the whole 
period analysed in this study (particularly data from 
2018). However, as PMM have increased the supply of 
physicians across the country, we partially captured its 
contribution by controlling the PHC coverage.
Implication for policy
Our results suggest that P4P can contribute to improve 
quality of care at PHC setting, particularly by reducing 
avoidable hospitalisations. However, caution is needed in 
any extrapolation of our results to other LMICs. PMAQ 
has beneficiated from a long period of investment in 
PHC in Brazil, although this investment was insufficient 
in view of the health needs of the Brazilian population. 
The role of FHT has been improved since it was imple-
mented in the mid- 1990s, as well as political arrangements 
for cooperation between municipalities and community 
participation on health decisions. This context probably 
provided institutional background to enhance better 
results of PMAQ.
Moreover, decision- makers must include monitoring 
and evaluation framework along to health policy imple-
mentation to identify expected and unexpected results. It 
would allow decision- makers to make timely adjustments, 
avoiding inefficiencies and health inequalities among 
population groups.
Finally, PMAQ was discontinued by the Brazilian 
Ministry of Health in December 2019, establishing new 
bases for PHC funding.47 Although P4P had remained, it 
was completely reformulated, replacing hundreds of indi-
cators, external evaluation, and equity concerns by very 
few indicators (just seven), restricted to few health condi-
tions. Several authors have criticised the new funding of 
PHC and its impact on access and quality of care.48 49 Our 
results can shed some light on the debate on P4P adjust-
ments in the Brazilian context.
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